605507 国邦医药
已收盘 02-06 15:00:00
资讯
新帖
简况
国邦医药（605507）2.57亿股限售股将于2月2日解禁，占总股本46.01%
证券之星 · 02-02
国邦医药（605507）2.57亿股限售股将于2月2日解禁，占总股本46.01%
每周股票复盘：国邦医药（605507）已回购1.39%股份
证券之星 · 01-02
每周股票复盘：国邦医药（605507）已回购1.39%股份
国邦医药（605507）披露股份回购进展公告，12月31日股价上涨0.57%
证券之星 · 2025-12-31
国邦医药（605507）披露股份回购进展公告，12月31日股价上涨0.57%
国邦医药（605507）披露第二期员工持股计划完成非交易过户暨购买完成，12月15日股价上涨1.51%
证券之星 · 2025-12-15
国邦医药（605507）披露第二期员工持股计划完成非交易过户暨购买完成，12月15日股价上涨1.51%
国邦医药（605507）披露第二期员工持股计划实施进展，12月11日股价下跌1.02%
证券之星 · 2025-12-11
国邦医药（605507）披露第二期员工持股计划实施进展，12月11日股价下跌1.02%
国邦医药（605507）披露股份回购进展公告，12月02日股价下跌0.37%
证券之星 · 2025-12-02
国邦医药（605507）披露股份回购进展公告，12月02日股价下跌0.37%
国邦医药（605507）披露第二期员工持股计划，11月28日股价下跌0.42%
证券之星 · 2025-11-28
国邦医药（605507）披露第二期员工持股计划，11月28日股价下跌0.42%
国邦医药（605507）披露第二期员工持股计划草案，11月24日股价上涨0.35%
证券之星 · 2025-11-24
国邦医药（605507）披露第二期员工持股计划草案，11月24日股价上涨0.35%
每周股票复盘：国邦医药（605507）回购股份达1.04%并召开三季报说明会
证券之星 · 2025-11-23
每周股票复盘：国邦医药（605507）回购股份达1.04%并召开三季报说明会
国邦医药（605507）披露召开2025年第三季度业绩说明会，11月20日股价上涨0.35%
证券之星 · 2025-11-20
国邦医药（605507）披露召开2025年第三季度业绩说明会，11月20日股价上涨0.35%
国邦医药(605507.SH)累计回购1.04%股份 耗资1.12亿元
智通财经网 · 2025-11-19
国邦医药(605507.SH)累计回购1.04%股份 耗资1.12亿元
国邦医药（605507）披露公司取消监事会并修改《公司章程》议案获通过，11月06日股价上涨1.31%
证券之星 · 2025-11-06
国邦医药（605507）披露公司取消监事会并修改《公司章程》议案获通过，11月06日股价上涨1.31%
国邦医药(605507.SH)拟推第二期员工持股计划
智通财经 · 2025-11-06
国邦医药(605507.SH)拟推第二期员工持股计划
国邦医药(605507.SH)累计回购537.53万股 耗资1.03亿元
智通财经 · 2025-11-03
国邦医药(605507.SH)累计回购537.53万股 耗资1.03亿元
国邦医药(605507)9月30日股东户数2.44万户，较上期减少2.52%
证券之星 · 2025-10-16
国邦医药(605507)9月30日股东户数2.44万户，较上期减少2.52%
国邦医药(605507.SH)发布前三季度业绩，归母净利润6.7亿元，同比增长15.78%
智通财经 · 2025-10-16
国邦医药(605507.SH)发布前三季度业绩，归母净利润6.7亿元，同比增长15.78%
每周股票复盘：国邦医药（605507）累计回购537.5万股
证券之星 · 2025-10-12
每周股票复盘：国邦医药（605507）累计回购537.5万股
国邦医药（605507）披露股份回购进展公告，10月9日股价下跌1.14%
证券之星 · 2025-10-09
国邦医药（605507）披露股份回购进展公告，10月9日股价下跌1.14%
国邦医药（605507）披露股东协议转让股份过户完成，9月29日股价下跌0.4%
证券之星 · 2025-09-29
国邦医药（605507）披露股东协议转让股份过户完成，9月29日股价下跌0.4%
每周股票复盘：国邦医药（605507）回购股份537.5万股
证券之星 · 2025-09-07
每周股票复盘：国邦医药（605507）回购股份537.5万股
加载更多
公司概况
公司名称：
国邦医药集团股份有限公司
所属行业：
医药制造业
上市日期：
2021-08-02
主营业务：
国邦医药集团股份有限公司的主营业务是医药及动物保健品领域相关产品的研发、生产和销售。公司的主要产品是医药原料药和制剂、关键医药中间体、动物保健品。公司先后荣获“中国化学制药行业工业企业综合实力百强企业”、全国工商联医药业商会“中国医药工业百强企业”、中国医药保健品进出口商会“中国西药原料行业会员企业出口十强”、“优秀院士专家工作站”、全国工商联医药业商会“2023-2024年度制药工业营业收入前百家企业”等荣誉称号。
发行价格：
32.57
{"stockData":{"symbol":"605507","market":"SH","secType":"STK","nameCN":"国邦医药","latestPrice":27.41,"timestamp":1770361201000,"preClose":26.94,"halted":0,"volume":5300890,"delay":0,"changeRate":0.0174,"floatShares":559000000,"shares":559000000,"eps":1.5622,"marketStatus":"已收盘","change":0.47,"latestTime":"02-06 15:00:00","open":26.9,"high":27.97,"low":26.76,"amount":146000000,"amplitude":0.0449,"askPrice":27.44,"askSize":5,"bidPrice":27.41,"bidSize":137,"shortable":0,"etf":0,"ttmEps":1.5622,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1770600600000},"marketStatusCode":5,"adr":0,"adjPreClose":26.94,"symbolType":"stock","openAndCloseTimeList":[[1770341400000,1770348600000],[1770354000000,1770361200000]],"highLimit":29.63,"lowLimit":24.25,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":558823500,"isCdr":false,"pbRate":1.85,"roa":"--","peRate":17.545769,"roe":"8.24%","epsLYR":1.4,"committee":0.488281,"marketValue":15317000000,"turnoverRate":0.0095,"status":0,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-02-09。","floatMarketCap":15317000000},"requestUrl":"/m/hq/s/605507","defaultTab":"news","newsList":[{"id":"2608871628","title":"国邦医药（605507）2.57亿股限售股将于2月2日解禁，占总股本46.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608871628","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608871628?lang=zh_cn&edition=full","pubTime":"2026-02-02 08:02","pubTimestamp":1769990546,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息整理，国邦医药于2月2日将有2.57亿股限售股份解禁，为公司追加承诺限售股份上市流通，占公司总股本46.01%。本次解禁后，公司已无限售股份。国邦医药主营业务：医药及动物保健品领域相关产品的研发、生产和销售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020200002735.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["605507","BK0239"],"gpt_icon":0},{"id":"2600035107","title":"每周股票复盘：国邦医药（605507）已回购1.39%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2600035107","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600035107?lang=zh_cn&edition=full","pubTime":"2026-01-02 02:03","pubTimestamp":1767290591,"startTime":"0","endTime":"0","summary":"截至2025年12月26日收盘，国邦医药报收于23.76元，较上周的23.28元上涨2.06%。本周，国邦医药12月26日盘中最高价报23.89元。国邦医药当前最新总市值138.59亿元，在化学制药板块市值排名37/150，在两市A股市值排名1400/5181。回购价格不超25元/股，资金总额1亿元至2亿元，回购期限为2025年3月11日至2026年3月10日。截至2025年12月31日，已累计回购股份7,767,174股，占公司总股本的1.39%，回购最高价24.59元/股，最低价18.61元/股，已支付总金额159,078,504.21元。上述回购进展符合相关规定。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010200000465.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","605507"],"gpt_icon":0},{"id":"2595224772","title":"国邦医药（605507）披露股份回购进展公告，12月31日股价上涨0.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595224772","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595224772?lang=zh_cn&edition=full","pubTime":"2025-12-31 22:10","pubTimestamp":1767190235,"startTime":"0","endTime":"0","summary":"截至2025年12月31日收盘，国邦医药报收于24.8元，较前一交易日上涨0.57%，最新总市值为138.59亿元。该股当日开盘24.66元，最高24.93元，最低24.56元，成交额达1.07亿元，换手率为1.43%。近日，国邦医药发布关于股份回购进展的公告。公告显示，公司于2025年3月10日召开董事会审议通过回购股份方案，拟使用自有及自筹资金通过集中竞价方式回购股份，用于员工持股计划或股权激励。上述回购进展符合相关规定。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025123100044602.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","605507"],"gpt_icon":0},{"id":"2591179526","title":"国邦医药（605507）披露第二期员工持股计划完成非交易过户暨购买完成，12月15日股价上涨1.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2591179526","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591179526?lang=zh_cn&edition=full","pubTime":"2025-12-15 17:58","pubTimestamp":1765792714,"startTime":"0","endTime":"0","summary":"截至2025年12月15日收盘，国邦医药报收于23.47元，较前一交易日上涨1.51%，最新总市值为131.16亿元。根据公司近日发布的公告，国邦医药集团股份有限公司第二期员工持股计划已实施完成。本次员工持股计划实际参与认购261人，缴纳资金18,458万元。公司回购专用账户中持有的8,225,474股公司股票已于2025年12月12日以非交易过户方式过户至员工持股计划专用账户，占公司总股本的1.47%，过户价格为22.44元/股。股票锁定期为自2025年12月16日起12个月。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121500023529.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","605507"],"gpt_icon":0},{"id":"2590142375","title":"国邦医药（605507）披露第二期员工持股计划实施进展，12月11日股价下跌1.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590142375","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590142375?lang=zh_cn&edition=full","pubTime":"2025-12-11 22:29","pubTimestamp":1765463375,"startTime":"0","endTime":"0","summary":"公司近日发布公告称，关于第二期员工持股计划的实施已取得进展。根据公告，国邦医药集团股份有限公司于2025年11月6日召开第三届董事会第一次会议，2025年11月24日召开2025年第二次临时股东会，审议通过第二期员工持股计划相关议案。公司拟将回购专用证券账户中持有的8,225,474股公司股票非交易过户至第二期员工持股计划专用账户，占公司总股本的1.47%，过户价格为22.44元/股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121100042139.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["605507","BK0239"],"gpt_icon":0},{"id":"2588051625","title":"国邦医药（605507）披露股份回购进展公告，12月02日股价下跌0.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588051625","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588051625?lang=zh_cn&edition=full","pubTime":"2025-12-02 22:35","pubTimestamp":1764686124,"startTime":"0","endTime":"0","summary":"截至2025年12月2日收盘，国邦医药报收于24.3元，较前一交易日下跌0.37%，最新总市值为135.79亿元。该股当日开盘24.27元，最高24.48元，最低24.13元，成交额达6673.01万元，换手率为0.91%。公司近日发布公告称，国邦医药集团股份有限公司于2025年3月10日召开董事会，审议通过回购股份方案，拟使用自有及自筹资金通过集中竞价方式回购股份，用于员工持股计划或股权激励。上述回购进展符合相关规定。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120200040221.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","605507"],"gpt_icon":0},{"id":"2586373337","title":"国邦医药（605507）披露第二期员工持股计划，11月28日股价下跌0.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586373337","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586373337?lang=zh_cn&edition=full","pubTime":"2025-11-28 22:33","pubTimestamp":1764340402,"startTime":"0","endTime":"0","summary":"截至2025年11月28日收盘，国邦医药报收于23.97元，较前一交易日下跌0.42%，最新总市值为133.95亿元。该股当日开盘24.1元，最高24.19元，最低23.71元，成交额达1.12亿元，换手率为1.55%。公司近日发布公告，披露第二期员工持股计划。持股计划存续期为24个月，锁定期为12个月，自股东会审议通过后6个月内完成股票购买。该计划需经公司股东会批准后实施。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112800040712.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","605507"],"gpt_icon":0},{"id":"2585984964","title":"国邦医药（605507）披露第二期员工持股计划草案，11月24日股价上涨0.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585984964","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585984964?lang=zh_cn&edition=full","pubTime":"2025-11-24 22:33","pubTimestamp":1763994803,"startTime":"0","endTime":"0","summary":"截至2025年11月24日收盘，国邦医药报收于22.98元，较前一交易日上涨0.35%，最新总市值为128.42亿元。根据近日发布的公告，国邦医药集团股份有限公司于2025年11月24日召开2025年第二次临时股东会，审议通过了《公司第二期员工持股计划（草案）》及其摘要、《公司第二期员工持股计划管理办法》以及提请股东会授权董事会办理员工持股计划相关事宜的议案。所有议案均获通过，关联股东已回避表决。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112400036138.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["605507","BK0239"],"gpt_icon":0},{"id":"2585510578","title":"每周股票复盘：国邦医药（605507）回购股份达1.04%并召开三季报说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=2585510578","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585510578?lang=zh_cn&edition=full","pubTime":"2025-11-23 04:08","pubTimestamp":1763842096,"startTime":"0","endTime":"0","summary":"本周关注点公司公告汇总：回购股份比例已达总股本1.04%，支付金额超1.12亿元。公司公告汇总：将于2025年11月28日召开第三季度业绩说明会。国邦医药集团股份有限公司将于2025年11月28日下午13:00-14:00通过上证路演中心网络互动方式召开2025年第三季度业绩说明会，介绍公司2025年第三季度报告的经营成果和财务状况。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112300001129.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["605507","BK0239"],"gpt_icon":0},{"id":"2584715881","title":"国邦医药（605507）披露召开2025年第三季度业绩说明会，11月20日股价上涨0.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584715881","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584715881?lang=zh_cn&edition=full","pubTime":"2025-11-20 22:38","pubTimestamp":1763649503,"startTime":"0","endTime":"0","summary":"截至2025年11月20日收盘，国邦医药报收于23.11元，较前一交易日上涨0.35%，最新总市值为129.14亿元。近日，国邦医药发布公告称，公司将于2025年11月28日下午13:00-14:00通过上证路演中心网络互动方式召开2025年第三季度业绩说明会，介绍公司2025年第三季度报告的经营成果和财务状况。投资者可于2025年11月21日至11月27日16:00前通过上证路演中心网站或公司邮箱info@gbgcn.com提前提问。会后可通过上证路演中心查看会议情况。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112000038535.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["605507","BK0239"],"gpt_icon":0},{"id":"2584155629","title":"国邦医药(605507.SH)累计回购1.04%股份 耗资1.12亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2584155629","media":"智通财经网","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584155629?lang=zh_cn&edition=full","pubTime":"2025-11-19 15:56","pubTimestamp":1763538971,"startTime":"0","endTime":"0","summary":"国邦医药(605507.SH)公告，公司截至2025年11月18日通过集中竞价交易...","market":"us","thumbnail":"https://img.zhitongcaijing.com/astock/19.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/astock/19.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1370951.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"国邦医药(605507.SH)累计回购1.04%股份 耗资1.12亿元","news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["605507","BK0239"],"gpt_icon":0},{"id":"2581575094","title":"国邦医药（605507）披露公司取消监事会并修改《公司章程》议案获通过，11月06日股价上涨1.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581575094","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581575094?lang=zh_cn&edition=full","pubTime":"2025-11-06 22:26","pubTimestamp":1762439181,"startTime":"0","endTime":"0","summary":"截至2025年11月6日收盘，国邦医药报收于22.44元，较前一交易日上涨1.31%，最新总市值为125.4亿元。出席会议的股东共381人，代表有表决权股份总数的69.1532%。所有议案均获得通过，其中特别决议议案已获有效表决权股份总数的2/3以上通过。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110600038242.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","605507"],"gpt_icon":0},{"id":"2581298050","title":"国邦医药(605507.SH)拟推第二期员工持股计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2581298050","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581298050?lang=zh_cn&edition=full","pubTime":"2025-11-06 17:45","pubTimestamp":1762422332,"startTime":"0","endTime":"0","summary":"智通财经APP讯，国邦医药(605507.SH)披露第二期员工持股计划(草案)，参加对象为对公司整体业绩和中长期发展具有重要作用和影响的公司(含合并报表子公司)董事(不含独立董事)、高级管理人员、中层管理人员及核心技术(业务)骨干，总人数不超过270人，其中参加持股计划的董事(不含独立董事)和高级管理人员共计8人。员工持股计划初始拟筹集资金总额不超过1.85亿元，其中员工自筹资金不超过1.85亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1366123.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["605507","BK0239"],"gpt_icon":0},{"id":"2580645562","title":"国邦医药(605507.SH)累计回购537.53万股 耗资1.03亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2580645562","media":"智通财经","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580645562?lang=zh_cn&edition=full","pubTime":"2025-11-03 16:06","pubTimestamp":1762157201,"startTime":"0","endTime":"0","summary":"智通财经APP讯，国邦医药(605507.SH)发布公告，截至2025年10月31日，公司通过集中竞价交易方式累计回购股份537.53万股，已回购股份占公司总股本的比例为0.96%，成交的最高价为19.88元/股，最低价为18.61元/股，已支付的总金额为1.03亿元(不含交易费用)。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1364424.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"国邦医药(605507.SH)累计回购537.53万股 耗资1.03亿元","news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","605507"],"gpt_icon":0},{"id":"2575171989","title":"国邦医药(605507)9月30日股东户数2.44万户，较上期减少2.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2575171989","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575171989?lang=zh_cn&edition=full","pubTime":"2025-10-16 17:08","pubTimestamp":1760605731,"startTime":"0","endTime":"0","summary":"证券之星消息，近日国邦医药披露，截至2025年9月30日公司股东户数为2.44万户，较6月30日减少631.0户，减幅为2.52%。在化学制药行业个股中，国邦医药股东户数低于行业平均水平，截至9月30日，化学制药行业平均股东户数为3.23万户。从股价来看，2025年6月30日至2025年9月30日，国邦医药区间涨幅为15.43%，在此期间股东户数减少631.0户，减幅为2.52%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101600026257.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","605507"],"gpt_icon":0},{"id":"2575157957","title":"国邦医药(605507.SH)发布前三季度业绩，归母净利润6.7亿元，同比增长15.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2575157957","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575157957?lang=zh_cn&edition=full","pubTime":"2025-10-16 16:51","pubTimestamp":1760604714,"startTime":"0","endTime":"0","summary":"智通财经APP讯，国邦医药(605507.SH)发布2025年三季度报告，前三季度，公司实现营业收入44.7亿元，同比增长1.17%。归属于上市公司股东的净利润6.7亿元，同比增长15.78%。归属于上市公司股东的扣除非经常性损益的净利润6.19亿元，同比增长9.59%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1355882.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"国邦医药(605507.SH)发布前三季度业绩，归母净利润6.7亿元，同比增长15.78%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["605507"],"gpt_icon":0},{"id":"2574468025","title":"每周股票复盘：国邦医药（605507）累计回购537.5万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2574468025","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574468025?lang=zh_cn&edition=full","pubTime":"2025-10-12 03:40","pubTimestamp":1760211627,"startTime":"0","endTime":"0","summary":"截至2025年10月10日收盘，国邦医药报收于23.28元，较上周的22.82元上涨2.02%。本周，国邦医药10月10日盘中最高价报23.32元。国邦医药当前最新总市值130.09亿元，在化学制药板块市值排名41/150，在两市A股市值排名1479/5158。截至2025年9月30日，公司累计回购股份5,375,274股，占公司总股本的0.96%，已支付总金额102,600,172.21元，回购最高价19.88元/股，最低价18.61元/股。上述回购进展符合相关规定及方案要求。公司将继续按规定推进回购，并及时履行信息披露义务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101200000974.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["605507","BK0239"],"gpt_icon":0},{"id":"2574130266","title":"国邦医药（605507）披露股份回购进展公告，10月9日股价下跌1.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2574130266","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574130266?lang=zh_cn&edition=full","pubTime":"2025-10-09 17:42","pubTimestamp":1760002976,"startTime":"0","endTime":"0","summary":"截至2025年10月9日收盘，国邦医药报收于22.56元，较前一交易日下跌1.14%，最新总市值为126.07亿元。该股当日开盘22.72元，最高22.79元，最低22.38元，成交额达8925.6万元，换手率为1.31%。公司近日发布关于股份回购进展的公告。截至2025年9月30日，公司累计回购股份5,375,274股，占公司总股本的0.96%，已支付总金额102,600,172.21元，回购最高价19.88元/股，最低价18.61元/股。上述回购符合相关规定及方案要求。公司将继续按规定推进回购，并及时履行信息披露义务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025100900023729.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","605507"],"gpt_icon":0},{"id":"2571337513","title":"国邦医药（605507）披露股东协议转让股份过户完成，9月29日股价下跌0.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2571337513","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2571337513?lang=zh_cn&edition=full","pubTime":"2025-09-29 22:37","pubTimestamp":1759156634,"startTime":"0","endTime":"0","summary":"截至2025年9月29日收盘，国邦医药报收于22.22元，较前一交易日下跌0.4%，最新总市值为124.17亿元。近日，国邦医药发布公告称，公司股东仕琦汇、洪德辉、世庆德与浙江省国有资本运营有限公司签署的《股份转让协议》已完成股份过户。根据公告，上述股东合计转让38,306,303股无限售流通股，占公司总股本的6.85%。本次转让已于2025年9月23日获上海证券交易所合规性确认，并于9月26日完成证券过户登记。受让方已承诺在12个月内不减持所受让股份。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092900035613.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","605507"],"gpt_icon":0},{"id":"2565546904","title":"每周股票复盘：国邦医药（605507）回购股份537.5万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2565546904","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565546904?lang=zh_cn&edition=full","pubTime":"2025-09-07 07:43","pubTimestamp":1757202189,"startTime":"0","endTime":"0","summary":"截至2025年9月5日收盘，国邦医药报收于23.58元，较上周的23.49元上涨0.38%。本周关注点公司公告汇总：国邦医药累计回购股份5,375,274股，占公司总股本的0.96%。公司公告汇总国邦医药关于股份回购进展公告：截至2025年8月31日，公司通过集中竞价交易方式累计回购股份5,375,274股，占公司总股本的0.96%，已支付总金额102,600,172.21元，实际回购价格区间为18.61元/股至19.88元/股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090700001694.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","605507"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1770478303475,"stockEarnings":[{"period":"1week","weight":-0.0018},{"period":"1month","weight":0.1102},{"period":"3month","weight":0.2032},{"period":"6month","weight":0.1876},{"period":"1year","weight":0.3848},{"period":"ytd","weight":0.1052}],"compareEarnings":[{"period":"1week","weight":-0.0127},{"period":"1month","weight":-0.0049},{"period":"3month","weight":0.017},{"period":"6month","weight":0.1184},{"period":"1year","weight":0.243},{"period":"ytd","weight":0.0244}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"国邦医药集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"24399人(较上一季度减少2.52%)","perCapita":"22903股","listingDate":"2021-08-02","address":"浙江省绍兴市新昌县省级高新技术产业园区兴梅大道60号","registeredCapital":"55882万元","survey":" 国邦医药集团股份有限公司的主营业务是医药及动物保健品领域相关产品的研发、生产和销售。公司的主要产品是医药原料药和制剂、关键医药中间体、动物保健品。公司先后荣获“中国化学制药行业工业企业综合实力百强企业”、全国工商联医药业商会“中国医药工业百强企业”、中国医药保健品进出口商会“中国西药原料行业会员企业出口十强”、“优秀院士专家工作站”、全国工商联医药业商会“2023-2024年度制药工业营业收入前百家企业”等荣誉称号。","listedPrice":32.57},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"国邦医药(605507)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供国邦医药(605507)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"国邦医药,605507,国邦医药股票,国邦医药股票老虎,国邦医药股票老虎国际,国邦医药行情,国邦医药股票行情,国邦医药股价,国邦医药股市,国邦医药股票价格,国邦医药股票交易,国邦医药股票购买,国邦医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"国邦医药(605507)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供国邦医药(605507)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}